Dalpke AH, Heeg K.CpG-DNA as immune response modifier[J].Int J Med Microbiol, 2004, 294(5):345-354.
[4]
Wang X, Bao M, Wan M, et al.A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine[J].Vaccine, 2008, 26(15):1893-1901.
[5]
He H, Genovese KJ, Nisbet DJ, et al.Synergy of CpG oligodeoxynucleotide and double-stranded RNA(poly I:C)on nitric oxide induction in chicken peripheral blood monocytes[J].Mol Immunol, 2007, 44(12):3234-3242.
[6]
Li IW, Chan KH, To KW, et al.Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses[J].J Clin Virol, 2009, 46(4):325-330.
[7]
Komorowska A, Komorowski J, Bsnsdik M, et al.Cytokines locally produced by lymphocytes removed from the hypertrophic nasopharyngeal and palatine tonsils[J].Int J Pediatr Otorhi, 2005, 69(7):937-941.
[8]
Alexopoulou L, Holt AC, Medzhitov R, et al.Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3[J].Nature, 2001, 413(6857):732-738.
